Recent challenges in cardiology include the rapid integration of digital health technologies, which, while offering opportunities for remote monitoring and personalized care, also present challenges related to data security, interoperability, and the ethical use of patient information. The emergence of novel cardiovascular therapeutics, including gene and cell-based therapies, brings new possibilities for treatment but poses challenges in terms of regulatory frameworks, long-term safety assessments, and equitable access. Another challenge is the impact of environmental factors on cardiovascular health, with air pollution, climate change, and urbanization influencing the prevalence and severity of cardiovascular diseases. The dynamic nature of infectious diseases, as exemplified by the COVID-19 pandemic, also presents challenges in understanding the long-term cardiovascular consequences of viral infections. Navigating these challenges requires ongoing collaboration among clinicians, researchers, policymakers, and technology developers to develop comprehensive and adaptable strategies for addressing the multifaceted aspects of cardiovascular health in an ever-changing global context.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia